The test evaluates circulating cells in the bloodstream by analyzing their cellular characteristics and abnormalities. Abnormal cells may be observed in various conditions, including cancer and vascular endothelial inflammation.
This test is suitable for individuals seeking to evaluate cellular characteristics and abnormalities that may be associated with conditions such as cancer or vascular endothelial inflammation. The results provide supplementary information for an initial health assessment.
The test evaluates circulating cells in the bloodstream for cellular abnormalities that may be associated with cancer or vascular endothelial inflammation, along with an assessment of cancer biomarkers in men.
Suitable for individuals seeking to assess cellular abnormalities associated with cancer or vascular endothelial inflammation, as well as those with a family history of cancer.
The test evaluates circulating cells in the bloodstream for cellular abnormalities that may be associated with cancer or vascular endothelial inflammation, along with an assessment of cancer biomarkers in women.
Suitable for individuals seeking to assess cellular abnormalities associated with cancer or vascular endothelial inflammation, as well as those with a family history of cancer.
If your test result is normal No abnormal cells were found. This is a good sign, but does not confirm the absence of all disease. Continue caring for your health and having regular checkups as appropriate. If you have unusual symptoms or health concerns, consult a physician.
If your test result is abnormal Abnormal cells requiring further assessment were found. This does not mean you have a disease or cancer, so there is no need to panic. A physician will consider your health history and symptoms and recommend appropriate, targeted further testing.
Blood tumor markers alone cannot specifically determine whether a person has cancer. Elevated values may be associated with inflammation, infection or some non-cancerous conditions. Results should therefore inform assessment and consideration of further testing as appropriate.
Likewise, screening for abnormal cells in blood may identify cell features that warrant further assessment. An abnormal result does not necessarily mean cancer, and clinical information and other tests are still needed.
Considering the results together may help a physician make a more comprehensive assessment, but cannot directly confirm cancer. Further testing may be needed as appropriate.
The detection of abnormal-looking circulating endothelial cells has been studied continuously by multiple research groups in several countries, with published academic evidence supporting this work.
Consider factors that may have a temporary effect A physician will take a further health history, including smoking within 24 hours, recent infection or acute illness, injury or major surgery, and pre-existing blood disorders.
Assess heart and vascular health Consider heart and vascular factors such as blood lipids, hs-CRP, blood pressure, kidney function and long-term blood glucose as part of an overall health assessment.
Further testing as appropriate If the cause remains unidentified, further testing may be considered, such as immune system testing, screening based on age and risk factors, or repeat testing to assess whether the abnormality persists.
These steps are information for consideration only. Appropriate further testing and care depend on a physician’s judgment, based on each person’s history, symptoms and health factors.
No. This test is not a diagnosis of any particular disease. An abnormal finding means cells requiring further assessment were found, which may relate to several factors, such as vascular disease, autoimmune disease or other conditions. A physician will consider your health history and symptoms to recommend appropriate further testing.
Tumor markers measure certain protein levels in blood, while this test directly assesses cell appearance and staining. Neither method can diagnose disease. Testing together provides information from different perspectives for a more comprehensive health assessment.
Avoid smoking for at least 24 hours before the draw — it interferes with the result. If you have recently had an infection, an acute illness, a major injury or surgery, tell our team in advance so we can schedule at a more suitable time.
ทราบผลเมื่อไร?
ภายใน 72 ชั่วโมงหลังเจาะเลือด รับผลผ่านอีเมลหรือ LINE พร้อมคำอธิบายผล
Within 72 hours of the blood draw, delivered by e-mail or LINE with an explanation of what it means.
Typically every 6 to 12 months, depending on your previous result and your own risk profile. After an abnormal result your doctor may suggest repeating it sooner to confirm the finding persists.